Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Apellis Pharmaceuticals, Inc. Put Options Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $83.4 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
295Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$229 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$227 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$221 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$189 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$179 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.04B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...